UK markets close in 2 hours 20 minutes

Assembly Biosciences, Inc. (ASMB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.53-0.19 (-1.29%)
At close: 04:00PM EDT
14.87 +0.34 (+2.34%)
Pre-market: 09:09AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-51,355
-61,228
-93,092
-129,855
-62,152
Depreciation & amortisation
358
450
498
466
691
Deferred income taxes
-
-
0
-2,531
0
Stock-based compensation
4,023
5,119
6,593
5,237
21,853
Change in working capital
74,428
76,341
-2,122
-11,401
-30,309
Accounts receivable
674
901
-608
894
2,144
Accounts payable
-497
-2,032
-166
-1,939
2,867
Other working capital
27,538
22,488
-84,565
-96,492
-65,177
Other non-cash items
3,011
3,507
3,505
3,840
6,964
Net cash provided by operating activities
27,807
22,743
-84,463
-93,396
-62,957
Cash flows from investing activities
Investments in property, plant and equipment
-
-255
-102
-3,096
-2,220
Purchases of investments
-137,636
-133,922
-27,583
-160,446
-193,188
Sales/maturities of investments
76,015
65,015
116,825
187,700
263,478
Net cash used for investing activities
-61,866
-69,138
90,640
26,515
68,070
Cash flows from financing activities
Common stock issued
9,197
13,689
325
52,806
5,452
Other financing activities
134,661
-
-
-
-
Net cash used provided by (used for) financing activities
9,326
13,818
614
53,064
7,599
Net change in cash
-24,733
-32,577
6,791
-13,817
12,712
Cash at beginning of period
43,482
52,418
45,627
59,444
46,732
Cash at end of period
18,749
19,841
52,418
45,627
59,444
Free cash flow
Operating cash flow
27,807
22,743
-84,463
-93,396
-62,957
Capital expenditure
-
-255
-102
-3,096
-2,220
Free cash flow
27,538
22,488
-84,565
-96,492
-65,177